Beyer-Westendorf J - Search Results

1

Peri-interventional management of novel oral anticoagulants in daily care: results from the prospective Dresden NOAC registry.

Beyer-Westendorf J, Gelbricht V, Förster K, Ebertz F, Köhler C, Werth S, Kuhlisch E, Stange T, Thieme C, Daschkow K, Weiss N. Beyer-Westendorf J, et al. Eur Heart J. 2014 Jul 21;35(28):1888-96. doi: 10.1093/eurheartj/eht557. Epub 2014 Jan 6. Eur Heart J. 2014. PMID: 24394381

2

Nitric oxide and endothelin after lipid apheresis - a pilot study.

Beyer-Westendorf J, Seitz W, Jabs N, Bramlage P, Kuhlisch E, Julius U, Bornstein SR, Schellong SM. Beyer-Westendorf J, et al. Atheroscler Suppl. 2009 Dec 29;10(5):70-3. doi: 10.1016/S1567-5688(09)71815-X. Atheroscler Suppl. 2009. PMID: 20129379

3

Cancer in males and risk of venous thromboembolism.

Beyer-Westendorf J, Werth S, Halbritter K, Weiss N. Beyer-Westendorf J, et al. Thromb Res. 2010 Apr;125 Suppl 2:S155-9. doi: 10.1016/S0049-3848(10)70035-9. Thromb Res. 2010. PMID: 20433997 Review.

4

Central adjudication of venous ultrasound in VTE screening trials: reasons for failure.

Beyer-Westendorf J, Halbritter K, Platzbecker H, Damme U, Neugebauer B, Kuhlisch E, Schellong S. Beyer-Westendorf J, et al. J Thromb Haemost. 2011 Mar;9(3):457-63. doi: 10.1111/j.1538-7836.2010.04166.x. J Thromb Haemost. 2011. PMID: 21143379 Free article. Clinical Trial.

5

Rupture prone aneurysm of the inferior mesenteric artery complicated by mid aortic syndrome with occluded celiac and superior mesenteric arteries.

Werth S, Rodionov RN, Hinterseher I, Beyer-Westendorf J, Stroszczynski C, Weiss N, Bergert H. Werth S, et al. Vasa. 2011 Jan;40(1):73-7. doi: 10.1024/0301-1526/a000073. Vasa. 2011. PMID: 21283977 Review.

6

Trousseau's syndrome in a patient with adenocarcinoma of unknown primary and therapy-resistant venous thrombosis treated with dabigatran and fondaparinux.

Beyer-Westendorf J, Werth S, Folprecht G, Weiss N. Beyer-Westendorf J, et al. Br J Clin Pharmacol. 2011 Oct;72(4):715-6. doi: 10.1111/j.1365-2125.2011.03965.x. Br J Clin Pharmacol. 2011. PMID: 21392076 Free PMC article. No abstract available.

7

Efficacy and safety of venous thromboembolism prophylaxis with fondaparinux or low molecular weight heparin in a large cohort of consecutive patients undergoing major orthopaedic surgery - findings from the ORTHO-TEP registry.

Donath L, Lützner J, Werth S, Kuhlisch E, Hartmann A, Günther KP, Weiss N, Beyer-Westendorf J. Donath L, et al. Br J Clin Pharmacol. 2012 Dec;74(6):947-58. doi: 10.1111/j.1365-2125.2012.04302.x. Br J Clin Pharmacol. 2012. PMID: 22515679 Free PMC article.

8

Efficacy and safety of venous thromboembolism prophylaxis with apixaban in major orthopedic surgery.

Werth S, Halbritter K, Beyer-Westendorf J. Werth S, et al. Ther Clin Risk Manag. 2012;8:139-47. doi: 10.2147/TCRM.S24238. Epub 2012 Mar 23. Ther Clin Risk Manag. 2012. PMID: 22547932 Free PMC article.

9

Efficacy and safety of rivaroxaban or fondaparinux thromboprophylaxis in major orthopedic surgery: findings from the ORTHO-TEP registry.

Beyer-Westendorf J, Lützner J, Donath L, Radke OC, Kuhlisch E, Hartmann A, Weiss N, Werth S. Beyer-Westendorf J, et al. J Thromb Haemost. 2012 Oct;10(10):2045-52. doi: 10.1111/j.1538-7836.2012.04877.x. J Thromb Haemost. 2012. PMID: 22882706 Free article.

10

Determinants of intermediate term clinical outcome after endovascular below-knee interventions.

Köhler C, Halbritter K, Stroszczynski C, Mahlmann A, Beyer-Westendorf J, Weiss N. Köhler C, et al. Vasa. 2012 Nov;41(6):440-50. doi: 10.1024/0301-1526/a000234. Vasa. 2012. PMID: 23129040

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

240 results

Search Page